1670. Activity of Ceftolozane/Tazobactam and Comparators Against Clinical MDR and DTR Pseudomonas aeruginosa isolates – SMART United States 2018-2020

BACKGROUND: Antimicrobial resistance of P. aeruginosa to commonly used β-lactams is typically higher in isolates collected from ICU patients and those with hospital-acquired infections. P. aeruginosa with multidrug-resistance (MDR) or difficult-to-treat resistance (DTR) is especially challenging as...

Descripción completa

Detalles Bibliográficos
Autores principales: Lob, Sibylle, Hackel, Meredith, Siddiqui, Fakhar, Bauer, Karri A, DeRyke, Charles A, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752968/
http://dx.doi.org/10.1093/ofid/ofac492.1300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752968/
http://dx.doi.org/10.1093/ofid/ofac492.1300

Ejemplares similares